[Validation of an self-measurement blood pressure device].

PubWeight™: 0.87‹?›

🔗 View Article (PMID 3142412)

Published in Arch Mal Coeur Vaiss on June 01, 1988

Authors

B Fouqueray1, J Julien, J Y Pagny, X Jeunemaitre, P Sassano, C Battaglia, P F Plouin

Author Affiliations

1: Service d'hypertension artérielle, hôpital Broussais, Paris.

Articles by these authors

Human hypertension caused by mutations in WNK kinases. Science (2001) 8.71

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98

Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93

A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet (1993) 3.78

Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg (1992) 3.69

Ribonucleic acid composition of bacteria as a function of growth rate. J Mol Biol (1966) 3.48

Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet (1995) 3.42

Phylogeny of some Fusarium species, as determined by large-subunit rRNA sequence comparison. Mol Biol Evol (1989) 3.28

Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41

The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet (2001) 2.28

A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest (1997) 2.23

The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma. Ann Intern Med (1996) 1.87

Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77

Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension (1999) 1.64

Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol (1998) 1.56

Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55

Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab (1997) 1.52

Widespread dilatation of perivascular spaces: a leukoencephalopathy causing dementia. Neurology (1997) 1.50

The radial artery for coronary artery bypass grafting: clinical and angiographic results at five years. J Thorac Cardiovasc Surg (1998) 1.49

The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. J Clin Endocrinol Metab (1995) 1.49

Stenoses of renal branch arteries in fibromuscular dysplasia: results of percutaneous transluminal angioplasty. Radiology (1994) 1.46

Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. J Am Coll Cardiol (1990) 1.43

Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43

Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest (1997) 1.40

Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. J Urol (1995) 1.39

Single fiber EMG and spectral analysis of surface EMG in myotonia congenita with or without transient weakness. Muscle Nerve (1994) 1.39

Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines? J Hypertens (1999) 1.38

Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol (1990) 1.38

Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int (1993) 1.37

Polyneuropathy in Waldenström's macroglobulinemia. Deposition of M component on myelin sheaths. Arch Neurol (1978) 1.35

Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int (2001) 1.31

Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res (2001) 1.30

Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients. Br J Clin Pharmacol (1984) 1.30

Monoclonal antibodies against laminin A chain fragment E3 and their effects on binding to cells and proteoglycan and on kidney development. Exp Cell Res (1992) 1.28

Benefits of a computer-assisted education program for hypertensive patients compared with standard education tools. Patient Educ Couns (1995) 1.27

Left ventricular outflow obstruction after mitral valve repair (Carpentier's technique). Proposed mechanisms of disease. Circulation (1988) 1.27

Treatment of malignant pheochromocytoma. Horm Metab Res (2009) 1.25

Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med (1997) 1.23

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest (1990) 1.23

[Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)]. Nouv Presse Med (1981) 1.22

A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem (1995) 1.19

A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma. Horm Metab Res (2012) 1.18

Oculopharyngeal muscular dystrophy. A case with abnormal mitochondria and "fingerprint" inclusions. J Neurol Sci (1974) 1.17

Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol (2000) 1.16

Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens (1996) 1.16

Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy. Hum Mol Genet (1992) 1.14

Cloning of the nitrate reductase gene (niaD) of Aspergillus nidulans and its use for transformation of Fusarium oxysporum. Gene (1989) 1.14

Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens (2001) 1.12

Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab (1997) 1.12

Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens (2006) 1.12

Homozygosity for the R1268Q mutation in MRP6, the pseudoxanthoma elasticum gene, is not disease-causing. Biochem Biophys Res Commun (2000) 1.11

Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica (1984) 1.11

Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family. Neurology (1997) 1.11

Guillain-Barré syndrome and Hodgkin's disease--ultrastructural study of a peripheral nerve. J Neurol Sci (1980) 1.10

Familial idiopathic striopallidodentate calcifications. Neurology (1989) 1.10

Analysis of the prion protein gene in thalamic dementia. Neurology (1992) 1.09

Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens (1997) 1.09

Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine. Br J Clin Pharmacol (1987) 1.09

Evidence for an excitonic insulator phase in 1T-TiSe2. Phys Rev Lett (2007) 1.08

Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol (1987) 1.08

Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev (1997) 1.08

Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet (1999) 1.07

Compressibility of the carotid artery in patients with pseudoxanthoma elasticum. Hypertension (2001) 1.06

Comparison of nurse- and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management. J Hypertens (2000) 1.06

Genetic analysis of the beta subunit of the epithelial Na+ channel in essential hypertension. Hypertension (1998) 1.06

No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J Clin Endocrinol Metab (1994) 1.06

Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension. Am J Med (1978) 1.05

Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies. J Hypertens (1996) 1.04

[Metabolism of ribonucleic acids in Escherichia coli deficient in phosphate]. Bull Soc Chim Biol (Paris) (1967) 1.04

Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol (1993) 1.03

Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Br Med J (Clin Res Ed) (1981) 1.03

DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4. Leukemia (2009) 1.03

Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension (1998) 1.02

Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril. Br J Obstet Gynaecol (1988) 1.02

Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. Exp Cell Res (1997) 1.02

[Post-radiotherapy anterior horn cell syndrome]. Rev Neurol (Paris) (1985) 1.02

Percutaneous transluminal angioplasty of the anomalous circumflex artery. J Interv Cardiol (2001) 1.01

Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome). Clin Exp Pharmacol Physiol (2001) 1.01

Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension. Pathol Biol (Paris) (1997) 1.01

Prion encephalopathy with insertion of octapeptide repeats: the number of repeats determines the type of cerebellar deposits. Neuropathol Appl Neurobiol (1998) 1.00

Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol (2001) 0.99

Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin Cancer Res (1996) 0.99

The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. J Nephrol (2004) 0.99

Hypertensive crisis in patient with phaeochromocytoma given metoclopramide. Lancet (1976) 0.99

Chronic demyelinating neuropathy with IgM-producing lymphocytes in peripheral nerve and delayed appearance of "benign" monoclonal gammopathy. Neurology (1984) 0.99

Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension (1993) 0.99

Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet (1999) 0.98

Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Gènes de l'Hypertension Artérielle Sévère à modérée Essentielle. J Hypertens (1998) 0.98

High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. J Neurosurg (1997) 0.97

Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation (1995) 0.97

Late central demyelination after Fischer's syndrome: MRI studies. J Neurol Neurosurg Psychiatry (1993) 0.97

A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet (2000) 0.97

Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab (2001) 0.96

Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension. Hypertension (1998) 0.95

Decision to treat mild hypertension after assessment by ambulatory monitoring and World Health Organisation recommendations. BMJ (1992) 0.94